Ablation of Toll-like receptor 4 mitigates central blood pressure response during hyperhomocysteinemia

Nevena Jeremic1, Gregory J Weber, Anastasia Familtseva

  • 1Department of Physiology, University of Louisville, Louisville, Kentucky, USA.

Abstract

Insights

High homocysteine levels promote hypertension and vascular remodeling by increasing mitochondrial fission in endothelial cells, leading to oxidative stress and inflammation. These effects were reversed in a specific mouse model, suggesting potential therapeutic targets.

Area of Science:

  • Cardiovascular Research
  • Vascular Biology
  • Hypertension Mechanisms

Background:

  • Hyperhomocysteinemia is linked to vascular remodeling and hypertension.
  • The role of mitochondrial dynamics and Toll-like receptor 4 in these processes requires further elucidation.

Purpose of the Study:

  • To investigate homocysteine's mechanisms on aortic wall, promoting vascular remodeling and hypertension.
  • To explore the involvement of Toll-like receptor 4 in homocysteine-induced vascular effects.

Main Methods:

  • Utilized five mouse strains, including CBS+/- mice, to study effects on aorta, heart, and blood.
  • Assessed blood pressure, vascular function, and expression of mitochondrial proteins, antioxidant markers, and collagen.

Main Results:

  • CBS+/- mice exhibited elevated blood pressure, reduced aortic response to vasoactive agents, increased oxidative stress, inflammation, and decreased nitric oxide.
  • Mitochondrial fission protein (Dynamin-related protein 1) was upregulated in CBS+/- mice.
  • Co-administration with C3H/HeJ strain normalized these detrimental effects.

Conclusions:

  • Endothelial cell mitochondrial fission dominates over fusion in hyperhomocysteinemia, causing cell loss and dysfunction.
  • This dysfunction, coupled with collagen deposition, contributes to inward aortic remodeling and hypertension.

Related Concept Videos

Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.2K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.3K
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
4.6K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
651
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
790
Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
6.7K